Drugs / PESAMPATOR
last change Apr 2022 re-read 2 minutes ago

PESAMPATOR

also known as PF-04958242 · BIIB104 · PF-4958242

Small molecule

Developed for
schizophrenia · sensorineural hearing loss disorder
Investigated by
Biogen · Yale University

Trials 16 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 114 trials
Phase 1 NCT05148481 Nov 2021 → Jan 2022 Biogen Completed No outcome recorded
Phase 1 NCT04068532 Nov 2019 → Nov 2020 Biogen Completed No outcome recorded
Phase 1 NCT04079101 Oct → Dec 2019 Biogen Completed No outcome recorded
Phase 1 NCT02341482 Feb → Mar 2015 Biogen Completed No outcome recorded
Phase 1 NCT02332798 Jan → Apr 2015 schizophrenia Biogen Completed No outcome recorded
Phase 1 NCT02228395 Sep → Nov 2014 Biogen Completed No outcome recorded
Phase 1 NCT01749098 Dec 2012 → Feb 2014 schizophrenia Biogen Completed No outcome recorded
Phase 1 NCT01646840 Jul → Sep 2012 Biogen Completed No outcome recorded
Phase 1 NCT01518920 Dec 2011 → Feb 2013 sensorineural hearing loss disorder Biogen Completed No outcome recorded
Phase 1 NCT01518894 Nov 2011 → Mar 2012 schizophrenia Biogen Completed No outcome recorded
Phase 22 trials
Phase 2 NCT03745820 Nov 2018 → Mar 2022 schizophrenia Biogen Completed No outcome recorded
Phase 2 NCT02855411 Aug → Sep 2016 schizophrenia Biogen Terminated No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT05152485 Comparator Dec 2021 → Jan 2022 Biogen Completed No outcome recorded

Evidence & citations 6 cited values

Every value below carries the sentence it was read from. 18 sources stand behind the page.

FieldValueCited text
Known as PESAMPATOR ChEMBL registry synonym — accepted as the source's own label CHEMBL5095022
Known as BIIB104 ClinicalTrials.gov intervention name — accepted as the source's own label NCT03745820
4

NCT05152485

NCT04068532

NCT05148481

NCT04079101

Known as PF-04958242 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01159483
11

NCT01518894

NCT01518920

NCT01646840

NCT02228395

NCT01749098

NCT02341482

NCT01365338

NCT01511510

NCT01238679

NCT02332798

NCT02855411

Known as PF-4958242 ChEMBL registry synonym — accepted as the source's own label CHEMBL5095022
Modality Small molecule CHEMBL5095022
Route Oral “administered orally” NCT01159483